Programme Thesis
This NIH R01 programme funds mechanistic research on how environmental exposures (e.g., pollutants, diet, toxins) alter gut-brain signaling pathways to contribute to neurological conditions such as Parkinson's, Alzheimer's, and multiple sclerosis. It exists to stimulate high-impact, hypothesis-driven studies that bridge environmental health, neuroscience, and gastroenterology, with an emphasis on translational potential.
Selection Criteria
1. Significance: Does the project address a critical problem in environmental exposures and gut-brain signaling? 2. Investigator(s): Are the PI and team well-suited (track record, expertise, institutional support)? 3. Innovation: Does the project propose novel concepts, approaches, or technologies? 4. Approach: Are the experimental design, methods, and analyses rigorous and feasible? 5. Environment: Does the scientific environment contribute to the likelihood of success (resources, collaborations)? 6. Overall Impact: Score based on the above, with priority for projects that integrate multi-omics, computational modeling, or human-relevant models.
Past Winners / Cohort Profiles
Typical R01 awardees are established investigators at US universities or research institutions (e.g., Harvard, UCSF, NIH intramural) with strong publication records in neuroscience, microbiome, or environmental health. Named examples are not listed on the page, but archetypes include mid-career to senior faculty with R01-equivalent funding history, often leading multi-PI teams. Early-stage investigators (ESIs) are eligible but face higher bar for preliminary data.
Ideal Candidate Fingerprint
A tenured or tenure-track faculty member at a US-based research university with a PhD or MD/PhD, 5+ years of independent funding, a lab with postdocs/students, and a track record of high-impact publications on gut-brain axis, environmental neurotoxicology, or related fields. The applicant should have strong preliminary data, institutional resources (e.g., animal facilities, core labs), and collaborative ties to clinicians or epidemiologists.
Recommended Framing
Eniola should frame their CCT model as a novel computational pharmacology framework to predict how environmental neurotoxins (e.g., heavy metals, pesticides) disrupt reward-memory encoding in addiction, a neurological condition. Leverage their independent research, preprints, and endorsements from Berridge, Gershman, Daw, and Mattar to demonstrate intellectual leadership, while proposing a collaboration with a US-based PI (e.g., at Michigan or Harvard) to meet institutional eligibility. Emphasize the Africa angle: environmental exposures in LMICs are understudied, and their Bayesian/TDA tools offer a scalable, low-cost approach to identify gut-brain signaling disruptions.
Watch Out
1. Ineligibility: R01 requires the applicant organization to be a US institution (university, non-profit, or for-profit); Eniola as an independent researcher in Nigeria is not eligible as a PI. 2. No preliminary data on gut-brain signaling specifically (CCT focuses on reward-memory, not gut-brain). 3. Lack of US-based institutional support and co-investigator with R01 experience. 4. No mention of environmental exposure measures in their prior work.